DND PharmaTech Inc
KOSDAQ:347850
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
KR |
|
Aker ASA
OTC:AKAAF
|
NO |
|
A
|
AMN Healthcare Services Inc
XMUN:HCQ
|
US |
|
Tyra Biosciences Inc
NASDAQ:TYRA
|
US |
|
Affirm Holdings Inc
NASDAQ:AFRM
|
US |
|
C
|
Crealogix Holding AG
XBER:CX1
|
CH |
|
I
|
Indo Thai Securities Ltd
BSE:533676
|
IN |
|
S
|
Spectral Medical Inc
OTC:EDTXF
|
CA |
|
Yoc AG
F:YOC
|
DE |
|
U
|
Ucore Rare Metals Inc
OTC:UURAF
|
CA |
|
Genfit SA
OTC:GNFTY
|
FR |
|
P
|
Prismaflex International SA
SWB:RFX
|
FR |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
|
Globalfoundries Inc
NASDAQ:GFS
|
US |
|
Datadog Inc
LSE:0A3O
|
US |
|
R
|
RWE AG
OTC:RWNFF
|
DE |
|
R
|
Recreate ASA
OSE:RCR
|
NO |
|
D'Ieteren Group NV
OTC:SIETY
|
BE |
|
Tilaknagar Industries Ltd
BSE:507205
|
IN |
|
N
|
Nesco Ltd
NSE:NESCO
|
IN |
|
E
|
ESR Cayman Ltd
HKEX:1821
|
HK |
|
F
|
Fiserv Inc
F:FIV
|
US |
|
M
|
Manz AG
XMUN:M5Z
|
DE |
|
P
|
Proximus NV
F:BX7
|
BE |
Bankruptcy Probability
DND PharmaTech Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
DND PharmaTech Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
3T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
DND PharmaTech Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, DND PharmaTech Inc has total debt of 4.6B KRW. This includes both short-term (0 KRW) and long-term (4.6B KRW) debt.
You can find a full breakdown on its Balance Sheet.
